Pulmonary surfactant and its apoproteins.
作者信息
Hawgood S, Clements J A
机构信息
Cardiovascular Research Institute, University of California San Francisco 94143-0130.
出版信息
J Clin Invest. 1990 Jul;86(1):1-6. doi: 10.1172/JCI114670.
Abstract
摘要
相似文献
1
Pulmonary surfactant and its apoproteins.肺表面活性物质及其载脂蛋白。
J Clin Invest. 1990 Jul;86(1):1-6. doi: 10.1172/JCI114670.
2
Functions of the surfactant proteins: a perspective.表面活性剂蛋白的功能：一种观点。
Pediatr Pulmonol. 1995 Feb;19(2):99-104. doi: 10.1002/ppul.1950190205.
3
Surfactant-associated proteins (SP-A, SP-B) are increased proportionally to alveolar phospholipids in sheep silicosis.在绵羊矽肺中，表面活性物质相关蛋白（SP-A、SP-B）与肺泡磷脂成比例增加。
Lung. 1993;171(2):63-74. doi: 10.1007/BF00542334.
4
[Pulmonary surfactant apoproteins structure and biological activity].[肺表面活性物质载脂蛋白的结构与生物活性]
Seikagaku. 1989 Jan;61(1):30-3.
5
Surfactant--a review for pediatric surgeons.表面活性剂——给小儿外科医生的综述
J Pediatr Surg. 2000 Dec;35(12):1687-700. doi: 10.1053/jpsu.2000.19214.
6
[Recent advances in pulmonary surfactant research with special reference to surfactant apoproteins].
Kokyu To Junkan. 1990 Aug;38(8):722-35.
7
[Recent advances in molecular biology with respect to pulmonary surfactant apoproteins].[肺表面活性物质载脂蛋白的分子生物学最新进展]
Nihon Rinsho. 1996 Feb;54(2):334-40.
8
Pulmonary surfactant-associated proteins.肺表面活性物质相关蛋白
Gen Pharmacol. 1988;19(3):361-8. doi: 10.1016/0306-3623(88)90029-8.
9
Effects of proteinosis surfactant proteins on the viability of rat alveolar macrophages.表面活性蛋白病中表面活性蛋白对大鼠肺泡巨噬细胞活力的影响。
Am J Respir Crit Care Med. 1997 Nov;156(5):1679-87. doi: 10.1164/ajrccm.156.5.97-03090.
10
The role of surfactant-associated proteins.表面活性物质相关蛋白的作用。
Am Rev Respir Dis. 1990 Oct;142(4):749-52. doi: 10.1164/ajrccm/142.4.749.
引用本文的文献
1
Life-saving effect of pulmonary surfactant in premature babies.肺表面活性剂对早产儿的救生作用。
J Clin Invest. 2024 May 1;134(9):e179948. doi: 10.1172/JCI179948.
2
Amphiphilic proteins coassemble into multiphasic condensates and act as biomolecular surfactants.两亲性蛋白共同组装成多相凝聚物，并充当生物分子表面活性剂。
Proc Natl Acad Sci U S A. 2021 Dec 21;118(51). doi: 10.1073/pnas.2109967118.
3
Detection of Cytokines and Collectins in Bronchoalveolar Fluid Samples of Patients Infected with and .在感染[具体病原体1]和[具体病原体2]的患者支气管肺泡灌洗样本中细胞因子和凝集素的检测
J Fungi (Basel). 2021 Nov 4;7(11):938. doi: 10.3390/jof7110938.
4
Acute or chronic pulmonary emphysema? Or both?-A contribution to the diagnosis of death due to violent asphyxiation in cases with pre-existing chronic emphysema.急性或慢性肺气肿？还是两者都有？——对既有慢性肺气肿的暴力窒息死亡案例的死因诊断的一点贡献。
Int J Legal Med. 2022 Jan;136(1):133-147. doi: 10.1007/s00414-021-02619-7. Epub 2021 Jun 28.
5
Necrotizing enterocolitis intestinal barrier function protection by antenatal dexamethasone and surfactant-D in a rat model.产前地塞米松和表面活性剂-D 对坏死性小肠结肠炎肠屏障功能的保护作用：大鼠模型研究。
Pediatr Res. 2021 Oct;90(4):768-775. doi: 10.1038/s41390-020-01334-0. Epub 2021 Jan 19.
6
Mechanisms of adhesion G protein-coupled receptor activation.黏附 G 蛋白偶联受体激活的机制。
J Biol Chem. 2020 Oct 9;295(41):14065-14083. doi: 10.1074/jbc.REV120.007423. Epub 2020 Aug 6.
7
On Top of the Alveolar Epithelium: Surfactant and the Glycocalyx.肺泡上皮之上：表面活性剂与糖萼。
Int J Mol Sci. 2020 Apr 27;21(9):3075. doi: 10.3390/ijms21093075.
8
Assessment of an model of pulmonary barrier to study the translocation of nanoparticles.评估一种用于研究纳米颗粒转运的肺屏障模型。
Toxicol Rep. 2014 May 12;1:157-171. doi: 10.1016/j.toxrep.2014.03.003. eCollection 2014.
9
Structure, genetics and function of the pulmonary associated surfactant proteins A and D: The extra-pulmonary role of these C type lectins.肺相关表面活性蛋白A和D的结构、遗传学与功能：这些C型凝集素在肺外的作用
Ann Anat. 2017 May;211:184-201. doi: 10.1016/j.aanat.2017.03.002. Epub 2017 Mar 27.
10
Surfactant proteins, SP-A and SP-D, in respiratory fungal infections: their role in the inflammatory response.表面活性蛋白SP-A和SP-D在呼吸道真菌感染中的作用：它们在炎症反应中的角色
Respir Res. 2016 Jun 1;17(1):66. doi: 10.1186/s12931-016-0385-9.
本文引用的文献
1
Properties, function and origin of the alveolar lining layer.肺泡衬里层的特性、功能及起源
Nature. 1955 Jun 25;175(4469):1125-6. doi: 10.1038/1751125b0.
2
Surface properties in relation to atelectasis and hyaline membrane disease.与肺不张和透明膜病相关的表面特性
AMA J Dis Child. 1959 May;97(5, Part 1):517-23. doi: 10.1001/archpedi.1959.02070010519001.
3
Surface tension of lung extracts.肺提取物的表面张力。
Proc Soc Exp Biol Med. 1957 May;95(1):170-2. doi: 10.3181/00379727-95-23156.
4
Analysis of labeling and clearance of lung surfactant phospholipids in rabbit. Evidence of bidirectional surfactant flux between lamellar bodies and alveolar lavage.兔肺表面活性物质磷脂的标记与清除分析。板层小体与肺泡灌洗之间双向表面活性物质通量的证据。
J Clin Invest. 1981 Sep;68(3):742-51. doi: 10.1172/jci110310.
5
Ventilation enhances pulmonary alveolar clearance of radioactive dipalmitoyl phosphatidylcholine in liposomes.通气可增强脂质体中放射性二棕榈酰磷脂酰胆碱的肺泡清除率。
Am Rev Respir Dis. 1980 Apr;121(4):709-21. doi: 10.1164/arrd.1980.121.4.709.
6
Subfractionation of lung surfactant. Implications for metabolism and surface activity.肺表面活性物质的亚组分分离。对代谢和表面活性的影响。
Biochim Biophys Acta. 1983 Jan 7;750(1):18-31. doi: 10.1016/0005-2760(83)90200-x.
7
The significance of reutilization of surfactant phosphatidylcholine.表面活性物质磷脂酰胆碱再利用的意义。
J Biol Chem. 1983 Apr 10;258(7):4159-65.
8
Protein composition of rabbit alveolar surfactant subfractions.兔肺泡表面活性物质亚组分的蛋白质组成。
Biochim Biophys Acta. 1984 Dec 21;791(3):320-32. doi: 10.1016/0167-4838(84)90343-1.
9
Role of calcium ions the structure and function of pulmonary surfactant.
Biochim Biophys Acta. 1984 Mar 27;793(1):18-27. doi: 10.1016/0005-2760(84)90048-1.
10
Artificial surfactant therapy in hyaline-membrane disease.透明膜病的人工表面活性剂治疗
Lancet. 1980 Jan 12;1(8159):55-9. doi: 10.1016/s0140-6736(80)90489-4.
Zotero 插件